https://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.png00adminhttps://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.pngadmin2020-10-26 11:07:222020-10-26 12:51:27The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
https://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.png00adminhttps://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.pngadmin2020-10-14 13:17:502020-10-14 13:17:5020-30% of patients with potentially curable breast cancer develop metastasis, denying breast cancer samurais the high quality and length of life. We need to dedicate ourselves to understanding the molecular mechanism underlying Metastatic Breast Cancer which will help identify personalized screening and treatment approaches to fight metastasis
https://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.png00adminhttps://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.pngadmin2020-10-08 15:45:442020-10-08 15:45:44Breast cancer remains a significant societal, clinical and scientific challenge. It is very crucial to understand the epidemiology, epi/genetics, molecular pathology, cell and protein biology and the influence of hormones on its development and progression. Breast cancer remains the leading cancer in Indian women and worldwide hence raising awareness for risk factors and early detection is critical to increase the quantity and quality of life.
Recent Comments